SGLT2 Inhibitors: Real-World Data Show Benefits Outweigh Risks SGLT2 Inhibitors: Real-World Data Show Benefits Outweigh Risks
Use of an SGLT2 inhibitor was associated with more lower limb amputations and nonvertebral fractures in US patients with CKD and type 2 diabetes receiving routine care, but benefits still outweigh risks.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Nephrology News Source Type: news
More News: Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Heart | SGLT2 Inhibitors | Urology & Nephrology